ROS1 inhibitor JYP0322
Term · Oncology and biomedicine · MLC-T-ONC-016585
An orally available selective inhibitor of the receptor tyrosine kinase c-ros oncogene 1 (ROS1), with potential antineoplastic activity. Upon oral administration, ROS1 inhibitor JYP0322 targets, binds to and inhibits ROS1. This inhibits proliferation of ROS1-driven tumor cells. ROS1, overexpressed, rearranged and/or mutated in certain cancer cells, plays a key role in cell growth and survival of various types of cancer cells.
| Identifier | MLC-T-ONC-016585 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016585",
"term": "ROS1 inhibitor JYP0322",
"field": "Oncology and biomedicine",
"definition": "An orally available selective inhibitor of the receptor tyrosine kinase c-ros oncogene 1 (ROS1), with potential antineoplastic activity. Upon oral administration, ROS1 inhibitor JYP0322 targets, binds to and inhibits ROS1. This inhibits proliferation of ROS1-driven tumor cells. ROS1, overexpressed, rearranged and/or mutated in certain cancer cells, plays a key role in cell growth and survival of various types of cancer cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ros1-inhibitor-jyp0322/"
}
Record 14,568 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.